Page last updated: 2024-08-24

gemcitabine and Cancer of the Urinary Tract

gemcitabine has been researched along with Cancer of the Urinary Tract in 136 studies

Research

Studies (136)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.21)	18.2507
2000's	49 (36.03)	29.6817
2010's	74 (54.41)	24.3611
2020's	10 (7.35)	2.80

Authors

Authors	Studies
Adachi, T; Azuma, H; Egawa, S; Fukuokaya, W; Fukushima, T; Hashimoto, T; Inamoto, T; Iwatani, K; Kimura, T; Komura, K; Miki, J; Mori, K; Nakamori, K; Nakamura, K; Nishimura, K; Nishio, K; Ohno, Y; Shiroki, R; Takahara, K; Tsuduki, S; Uchimoto, T; Urabe, F; Yamamoto, S; Yanagisawa, T; Yano, Y; Yoshizawa, A	1
Batteson, R; de Wit, R; Grivas, P; Keefe, S; Li, H; Meng, Y; Patterson, K; Pellissier, J; Prabhu, V; Xu, R; Zarabi, N; Zhong, Y	1
Bracco, OL; Frenkl, T; Freshwater, T; Keefe, S; Li, H; Li, M; Perini, R; Valiathan, C	1
Hikita, K; Honda, M; Iwamoto, H; Kimura, Y; Morizane, S; Nishikawa, R; Takenaka, A; Teraoka, S; Yumioka, T	1
Akita, H; Ando, R; Chaya, R; Etani, T; Iida, K; Kobayashi, D; Moritoki, Y; Nagai, T; Naiki, T; Nozaki, S; Okamura, T; Sugiyama, Y; Yanase, T; Yasui, T	1
Sridhar, SS	1
Fukui, I; Inoue, T; Masuda, H; Numao, N; Ogawa, M; Yamamoto, S; Yonese, J; Yuasa, T	1
Ando, R; Etani, T; Hamamoto, S; Iida, K; Kawai, N; Nagai, T; Naiki, T; Nozaki, S; Sugiyama, Y; Tasaki, Y; Yasui, T	1
Fujimiya, T; Kurihara, T; Nagatani, A; Ogawa, Y; Sasaki, H; Sasaki, T; Sunaga, T; Takahashi, N; Watanabe, T; Yamagishi, M	1
Aragon-Ching, JB; Bellmunt, J; Blake-Haskins, JA; Caserta, C; Costa, N; Davis, C; Demey, W; di Pietro, A; Fowst, C; Grivas, P; Gurney, H; Huang, B; Kalofonos, H; Kopyltsov, E; Laliberte, R; Loriot, Y; Park, SH; Petrylak, DP; Powles, T; Radulović, S; Sridhar, SS; Sternberg, CN; Tsuchiya, N; Ullén, A; Valderrama, BP; Voog, E; Wang, J	1
Cho, YM; Hong, B; Kim, YS; Lee, JL; Lee, Y	1
Atherton, PJ; Bajorin, D; Ballman, KA; Dreicer, R; Flaig, TW; Hahn, O; Halabi, S; Hoimes, C; Katragadda, S; Misleh, J; Morris, MJ; Mortazavi, A; Picus, J; Plimack, ER; Rosenberg, JE; Small, EJ; Stadler, WM; Sweeney, C; Tagawa, ST; Teply, BA; Vaena, D	1
Hamada, S; Kadowaki, D; Miyamura, S; Nishimura, F; Oniki, K; Saruwatari, J; Ushijima, T	1
Chen, CS; Cheng, CL; Chiu, KY; Ho, HC; Hung, SC; Li, JR; Ou, YC; Wang, SS; Yang, CK	1
Bellmunt, J; Blais, N; Blumenstein, B; Castellano, D; Eigl, BJ; Jacobs, C; Loriot, Y; Pal, S; Petrylak, DP; Retz, M; Senkus, E; Sridhar, SS; Sternberg, CN; Stewart, PS; Twardowski, P	1
Abe, H; Kamai, T; Kobayashi, M; Mizuno, T; Nishihara, D; Nukui, A; Sakamoto, K; Suzuki, I; Takei, K; Tokura, Y; Uematsu, T; Yamaguchi, Y	1
Akers, N; Albany, C; Bhardwaj, N; Chen, R; Domingo-Domenech, J; Donovan, MJ; Fleming, MT; Galsky, MD; Gnjatic, S; Hahn, NM; Hauke, RJ; Kim-Schulze, S; Losic, B; Oh, WK; Pal, SK; Patel, VG; Schadt, EE; Sfakianos, JP; Sonpavde, G; Starodub, A; Twardowski, P; Uzilov, AV; Wang, H; Yu, M; Zhao, Q	1
Ebara, S; Edamura, K; Hanamoto, M; Hayashi, N; Hirata, T; Ogura, K; Saika, T; Takamura, K	1
Kwon, WA; Lee, JW; Oh, TH; Park, SC; Seo, IY	1
Iguchi, T; Kato, M; Kuratsukuri, K; Nakatani, T; Nishihara, C; Takeyama, Y; Tamada, S; Yamasaki, T	1
Aujla, PK; Beckett, LA; Lara, PN; Li, Y; Pan, CX; Parikh, M; Robles, DA	1
Deshpande, H; Donadio, A; Hurwitz, ME; Kelly, WK; Markowski, P; Mehnert, JM; Mortazavi, A; Patel, J; Petrylak, DP; Stein, MN; Yao, X	1
Chang, HC; Chow, PM; Hong, JY; Hsu, FS; Huang, KH; Kuo, KL; Kuo, Y; Liao, SM; Lin, MC; Lin, WC; Liu, SH; Shi, CS; Shun, CT; Tsai, YC; Wu, JT; Yang, SP	1
Chen, C; Meng, X; Qin, Z; Song, N; Wang, Y; Xia, J; Xu, L; Zhang, Q; Zhou, X	1
Galsky, MD; Gore, JL; Holt, SK; Ramos, JD; Schade, GR; Wright, JL; Yu, EY	1
Ishizuka, Y; Nakamichi, H; Sasano, T; Shiokawa, M; Tokou, U; Tsuji, D; Yabe, K; Yamamoto, K; Yoneda, T	1
Bellmunt, J; Rodriguez-Vida, A	1
Choi, HY; Jeon, HG; Jeon, SS; Jeong, JY; Lee, HM; Seo, SI; Song, W; Sung, HH	1
Chi, KN; Eigl, BJ; Forbes, C; Parimi, S; Tsang, ES	1
Kawakita, M; Matsumoto, K; Muguruma, K; Segawa, T; Sumiyoshi, T; Utsunomiya, N	1
Fujii, Y; Fukui, I; Kitsukawa, S; Masuda, H; Saito, K; Sakura, M; Urakami, S; Yamamoto, S; Yano, A; Yonese, J; Yuasa, T	1
Ando, R; Etani, T; Hashimoto, Y; Kawai, N; Kohri, K; Naiki, T; Okada, A; Okamura, T; Tozawa, K; Yasui, T	1
Albers, P; de Geeter, P; Fenner, M; Feyerabend, S; Hakenberg, O; Heidenreich, A; Heinzer, H; Kamradt, J; Klotz, T; Krege, S; Kühn, M; Retz, M; Rexer, H; Roigas, J; Schrader, M; vom Dorp, F; Wülfing, C; Zastrow, S	1
Alva, A; Daignault, S; Hussain, M; Smith, DC	1
Arai, Y; Ito, A; Kaiho, Y; Mitsuzuka, K; Nakagawa, H; Namiki, S; Saito, H; Sato, K; Yamada, S; Yamashita, S	1
Lee, JL; Park, JH	1
Barber, J; Casbard, A; Chester, J; Cowles, R; Crabb, S; Elliott, T; Evans, J; Geldart, T; Griffiths, G; Huddart, RA; Jones, RJ; Mead, G; Protheroe, A; Smith, J	1
Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Sycova-Mila, Z	1
Culine, S	2
Abe, H; Horie, S; Ide, H; Isotani, S; Kamai, T; Kitamura, K; Muto, S; Noguchi, T; Sugiura, S; Yamaguchi, R	1
Baras, A; Berman, D; Bivalacqua, TJ; Eisenberger, M; Faraj, S; Gandhi, NM; Hahn, NM; Hoque, MO; Kates, M; Liu, JJ; Munari, E; Netto, GJ; Reis, LO; Schoenberg, MP	1
Fujita, T; Hirayama, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mochizuki, K; Nishi, M; Okazaki, M; Tabata, K; Taoka, Y	1
Kato, R; Kato, Y; Obara, W; Sato, J; Takata, R	1
Ahn, H; Hong, B; Hong, JH; Jeong, IG; Kim, YR; Lee, JL; Song, C; You, D	1
Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Ohyama, C; Yoneyama, T	1
Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F	1
Heo, DS; Keam, B; Kim, HH; Kim, M; Kim, TM; Ku, JH; Kwak, C; Lee, E; Lee, SH; Moon, KC	1
Chen, YY; Chiang, PH; Hsieh, MC; Huang, CH; Rau, KM; Su, YL	1
Hashimoto, K; Itoh, N; Shindo, T	1
Dykoski, R; Gruenberg, J; Gupta, P; Manivel, JC; Mesa, H	1
Bellmunt, J; Galsky, MD; Giannatempo, P; Naik, G; Necchi, A; Pond, GR; Raggi, D; Sonpavde, G	1
Han, KS; Hong, SJ; Kim, KH	1
Apolo, AB; Bajorin, DF; Furberg, HF; Ostrovnaya, I; Regazzi, AM; Rosenberg, JE; Tully, CM; Zabor, EC	1
Hagiwara, M; Hanai, K; Ichioka, D; Inoue, T; Kageyama, S; Kikuchi, E; Kinoshita, H; Matsui, Y; Mitsuzuka, K; Miyazaki, J; Nishiyama, H; Sugimoto, M; Wakeda, H; Yamamoto, S; Yuge, K	1
Campbell, MT; Carolla, RL; Harris, DR; Munsell, MF; Pagliaro, LC; Siefker-Radtke, AO	1
Ezaki, T; Kikuchi, E; Matsumoto, K; Mizuno, R; Morita, S; Oya, M; Shinoda, K	1
Endou, M; Nagamori, S; Takada, S; Tamaki, S	1
Bellmunt, J; Galsky, MD; Giannatempo, P; Grivas, P; Necchi, A; Pond, GR; Raggi, D; Sonpavde, G; Vogelzang, NJ	1
Fujie, K; Inoue, T; Ishitsuka, R; Kageyama, S; Keino, N; Kikuchi, E; Kinoshita, H; Matsui, Y; Mitsuzuka, K; Miyazaki, J; Nishiyama, H; Nomoto, T; Ogawa, O; Shiraishi, Y; Sugimoto, M; Wakeda, H	1
Azuma, T; Matayoshi, Y; Nagase, Y; Oshi, M; Sato, Y	1
Penel, N	1
Hirano, M; Iizuka, M; Kameda, M; Kikuchi, A; Kuromitsu, S; Nakayama, A; Nakazawa, T; Ozawa, T; Shindoh, N; Suzuki, T; Terasaka, T	1
Fukushi, K; Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Matsumoto, T; Narita, T; Ohyama, C; Soma, O; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Chess-Williams, R; Farr, SE; McDermott, CM	1
Fukushi, K; Hashimoto, Y; Hatakeyama, S; Koie, T; Narita, T; Ohyama, C; Tobisawa, Y; Yamamoto, H; Yoneyama, T	1
Cheng, T	1
Habuchi, T; Horikawa, Y; Inoue, T; Kumazawa, T; Narita, S; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Yuasa, T	1
Bajorin, D; Halabi, S; Philips, GK; Sanford, BL; Small, EJ	2
Beijnen, JH; Huitema, AD; Jansen, RS; Koolen, SL; Schellens, JH; Smit, WM; van Voorthuizen, T	1
Bellmunt, J; De Santis, M; de Wit, R; Kerst, JM; Leahy, M; Maroto, P; Marreaud, S; Mead, G; Skoneczna, I; Sylvester, R	1
Cho, JS; Cho, KS; Chung, BH; Doo, SH; Hong, SJ; Kim, CI; Kim, SJ; Song, KH; Song, YS; Yang, WJ	1
Arima, K; Kise, H; Soga, N; Sugimura, Y	1
Aoki, K; Ikeda, T; Kikugawa, T; Miura, N; Nishida, T; Ochi, T; Ozawa, A; Sasaki, T; Shimamoto, K; Tanji, N; Yanagihara, Y; Yokoyama, M	1
Gondo, T; Hamada, R; Hatano, T; Nakashima, J; Ohori, M; Satake, N; Tachibana, M; Takeuchi, H; Tanaka, A	1
Akino, H; Aoki, Y; Ito, H; Miwa, Y; Oyama, N; Yokoyama, O	1
Habuchi, T; Horikawa, Y; Inoue, T; Maita, S; Narita, S; Numakura, K; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Tsuruta, H	1
Chen, CY; Huang, AM; Li, JH; Liu, CH	1
Albers, P; Fimmers, R; Niegisch, G; Park, SI; Siener, R	1
Baba, S; Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K	1
Culine, S; Demery, ME; Pouessel, D; Thézenas, S	1
Ahn, H; Ahn, JH; Ahn, S; Hong, JH; Kim, CS; Kwon, JH; Lee, JL; Lim, HY; Park, SH; Song, C	1
Bellmunt, J; Collette, S; Daugaard, G; De Santis, M; de Wit, R; Gil, T; Kerst, JM; Leahy, M; Lorent, J; Maroto, P; Marreaud, S; Mead, G; Skoneczna, I; Sylvester, R	1
Bellmunt, J; Boehle, A; Chevreau, C; Collette, S; Daugaard, G; De Santis, M; de Wit, R; Laufman, LR; Marreaud, S; Mead, GM; Paz-Ares, L; Raghavan, D; Skoneczna, I; Sylvester, R; von der Maase, H; Winquist, E	1
Hoshina, A; Onishi, T; Sasaki, T	1
Kanetake, H; Matsuo, T; Miyata, Y; Nomata, K; Ohba, K; Sagara, Y; Sakai, H	1
Azuma, K; Fukumoto, T; Kikugawa, T; Miura, N; Miyauchi, Y; Shimamoto, K; Shirato, A; Tanji, N; Yanagihara, Y; Yokoyama, M	1
Kitamura, H; Masumori, N; Shindo, T; Tsukamoto, T	1
Agarwal, N; Boucher, KM; Galsky, MD; Hussain, SA; Kaufman, DS; Lorusso, V; Maughan, BL; Moore, MJ; Sonpavde, G; Von Der Maase, H	1
Apolo, AB; Bajorin, DF; Balar, AV; Gallagher, DJ; Garcia-Grossman, IR; Iasonos, A; Milowsky, MI; Mironov, S; Ostrovnaya, I; Regazzi, AM; Trout, A	1
Logothetis, C; Millikan, R	1
Colle, B; Debourdeau, P; Estival, JL; Pavic, M; Teixeira, L; Zammit, C	1
Calabrò, F; Sternberg, CN	1
Albanell, J; Baselga, J; Bellmunt, J; Carles, J; Climent, MA; Cortés-Funes, H; de la Cruz, JJ; Díaz-Rubio, E; González-Larriba, JL; Guillem, V; Paz-Ares, L	1
Brierre, JE; Buller, EJ; Cole, JL; Fontenot, MF; Lormand, NA; Rainey, JM; Rinaldi, DA; Stagg, MP	1
von der Maase, H	2
Alonso, L; Arrivi, A; Carles, J; Font, A; Garrido, P; Juan, O; Mellado, B; Nogué-Aliguer, M; Sáenz, A	1
Dreicer, R; George, CS; Manola, J; Roth, BJ; Schneider, DJ; Schwerkoske, JF; Wilding, G	1
Al-Mwalad, M; Albers, P; Becker, T; Brauers, A; Brkovic, D; Bub, P; Derigs, HG; Fassmann, C; Hamza, A; Hartlapp, J; Henss, H; Hertle, L; Jaeger, E; Jakse, G; Kälble, T; Kaldenbach, U; Knuth, A; Koser, M; Lehmann, J; Lippert, C; Loch, T; Melchior, H; Muschter, R; Otto, C; Piechota, HJ; Pomer, S; Potratz, C; Retz, M; Richter, AE; Roloff, J; Roth, S; Steiner, G; Stockamp, K; Stöckle, M; Tunn, U; Van Ahlen, H; Walz, P; Weinknecht, S; Weissbach, L; Winter, E; Wirth, M	1
Dawson, NA; Edelman, MJ; Houston, J; Lara, PN; Lauder, I; Law, LY; Meyers, FJ	1
Helke, C; Hoschke, B; May, M; Seehafer, M	1
Dorreen, M; Iscoe, N; Jonker, D; Wilson, JJ; Winquist, E; Wong, R	1
Mikami, K; Miki, T; Mizutani, Y	1
Alexopoulos, A; Ardavanis, A; Kandylis, C; Lainakis, G; Rigatos, G; Tryfonopoulos, D	1
Caponigro, F; Chollet, P; de Balincourt, C; Fiedler, W; Fumoleau, P; Geoffrois, L; Lacombe, D; Peters, GJ; Ravaud, A; Theodore, C; Vermorken, JB	1
Alexandre, J; Amsellem-Ouazana, D; Beuzeboc, P; Debré, B; Flam, T; Goldwasser, F; Guillevin, L; Mir, O; Ropert, S; Zerbib, M	1
Habuchi, T; Higashi, S; Itoh, N; Kamoto, T; Kinoshita, H; Nakamura, E; Nishiyama, H; Ogawa, O; Segawa, T; Takahashi, T; Yamamoto, S	1
Lorusso, V	1
Koga, H; Naito, S	1
Abdelatif, M; Bidault, F; Bouvet-Forteau, N; de Crevoisier, R; di Palma, M; Fizazi, K; Laplanche, A; Theodore, C; Wibault, P	1
Fukui, I; Ohkubo, Y; Tsukamoto, T; Yonese, J	1
Androulakis, N; Boukovinas, I; Georgoulias, V; Gioulmbasanis, I; Kalykaki, A; Kotsakis, A; Mavroudis, D; Papakotoulas, P; Polyzos, A; Vamvakas, L; Xenidis, N; Ziras, N	1
Hamada, H; Ikeda, T; Miyauchi, Y; Ochi, T; Ozawa, A; Shimamoto, K; Sugawara, T; Tanji, N; Toshino, A; Yanagaki, T; Yanagihara, Y; Yokoyama, M	1
Fujioka, H; Hatano, K; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tsujimoto, Y	1
Akaza, H; Miki, T; Miyanaga, N; Naito, S; Taniai, H; Usami, M	1
Aoki, K; Ikeda, T; Kikugawa, T; Ochi, T; Ozawa, A; Shimamoto, K; Tanji, N; Toshino, A; Yamaguchi, A; Yanagihara, Y; Yokoyama, M	1
Fléchon, A	1
Baldazzi, V; Carini, M; Crisci, A; Giordano, C; Grifoni, R; Lapini, A; Neri, B; Pantaleo, P; Raugei, A; Vannini, L	1
Baba, S; Irie, A; Iwamura, M; Matsumoto, K; Okazaki, M; Satoh, T	1
Alivizatos, G; Antoniou, N; Bamias, A; Chrisofos, M; Dimopoulos, MA; Karayiotis, E; Kastritis, E; Koureas, A; Lainakis, G; Skolarikos, A	1
Agarwal, M; Beer, TM; Crawford, ED; Goldman, B; Nichols, CR; Petrylak, DP; Ryan, CW	1
Ernst, DS; Huan, S; Moore, MJ; Murray, N; Tannock, IF	1
Antimi, M; De Lena, M; Frassineti, GL; Gridelli, C; Lorusso, V; Luporini, G; Oliva, C; Pacini, M; Pollera, CF	1
Andersen, L; Crinò, L; Dogliotti, L; von der Maase, H; Weinknecht, S	1
Bajorin, DF; Boyle, MG; Dodd, PM; Herr, H; Hilton, S; Icasiano, E; Kelly, WK; Mazumdar, M; McCaffrey, JA	1
Aisner, J; Carducci, M; Kaufman, D; Kuzel, T; Levine, EG; Murphy, B; Nicol, S; Oh, W; Raghavan, D; Stadler, W	1
Antimi, M; De Lena, M; De Vita, F; Lorusso, V; Manzione, L; Selvaggi, FP	1
Burris, HS; Greco, FA; Hainsworth, JD; Meluch, AA	1
Bajorin, DF	1
Albanell, J; Banús, JM; Baselga, J; Bastús, R; Batiste-Alentorn, E; Bellmunt, J; Carles, J; Climent, MA; Cortés-Funes, H; de la Cruz, JJ; Diaz-Rubio, E; Font, A; Gallardo, E; González-Larriba, JL; Guillem, V; López-Brea, M; Nogué, M; Paz-Ares, L; Sáenz, A	1
Sternberg, CN	1
Brooks, A; Crombie, C; Drummond, M; Gurney, H; Lau, H; Shannon, C	1
Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kalofonos, H; Kiamouris, C; Nicolaides, C; Pectasides, D; Visvikis, A; Xiros, N	1
Daliani, D; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Papandreou, CN; Tu, SM; Williams, D	1

Reviews

20 review(s) available for gemcitabine and Cancer of the Urinary Tract

Article	Year
Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible. American journal of clinical oncology, 2019, Volume: 42, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Eligibility Determination; Female; Gemcitabine; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2019
Different Chemotherapy Regimens in the Management of Advanced or Metastatic Urothelial Cancer: a Bayesian Network Meta-Analysis of Randomized Controlled Trials. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Blood Platelet Disorders; Cisplatin; Databases, Factual; Deoxycytidine; Disease-Free Survival; Doxorubicin; Gemcitabine; Humans; Neoplasm Staging; Paclitaxel; Randomized Controlled Trials as Topic; Survival Rate; Urologic Neoplasms	2018
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis. European urology, 2016, Volume: 69, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease Progression; Disease-Free Survival; Gemcitabine; Humans; Multivariate Analysis; Platinum Compounds; Risk Factors; Taxoids; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium	2016
Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Transitional Cell; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Neoplasm Metastasis; Survival Analysis; Taxoids; Treatment Outcome; Urologic Neoplasms	2017
Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond. Current opinion in supportive and palliative care, 2008, Volume: 2, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Paclitaxel; Receptor, ErbB-2; Trastuzumab; Urologic Neoplasms; Urothelium	2008
Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature. The oncologist, 2009, Volume: 14, Issue:9 Topics: Aged; Antimetabolites, Antineoplastic; Area Under Curve; Deoxycytidine; Gemcitabine; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Male; Nephrectomy; Palliative Care; Renal Dialysis; Urologic Neoplasms	2009
[Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Salvage Therapy; Urologic Neoplasms; Urothelium	2011
Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function. Anti-cancer drugs, 2012, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Kidney; Kidney Function Tests; Neoplasm Invasiveness; Paclitaxel; Randomized Controlled Trials as Topic; Urologic Neoplasms; Urothelium	2012
Docetaxel in the management of advanced or metastatic urothelial tract cancer. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:6 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Paclitaxel; Taxoids; Urologic Neoplasms	2002
[Gemcitabine-induced thrombotic microangiopathy]. Presse medicale (Paris, France : 1983), 2002, Apr-27, Volume: 31, Issue:16 Topics: Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Deoxycytidine; Gemcitabine; Humans; Male; Neoplasm Metastasis; Thrombosis; Urologic Neoplasms; Vascular Diseases	2002
New drugs and new approaches for the treatment of metastatic urothelial cancer. World journal of urology, 2002, Volume: 20, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cisplatin; Deoxycytidine; Doxorubicin; Drug Therapy; Gemcitabine; Humans; Methotrexate; Taxoids; Urologic Neoplasms; Urothelium; Vinblastine	2002
Gemcitabine in transitional cell carcinoma of the urothelium. Expert review of anticancer therapy, 2003, Volume: 3, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Gemcitabine; Humans; Urologic Neoplasms; Urothelium	2003
Pemetrexed in transitional cell carcinoma of the urothelium. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Pemetrexed; Thymidylate Synthase; Urologic Neoplasms; Urothelium	2004
[The second-line chemotherapy for urological cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Male; Methotrexate; Paclitaxel; Survival Rate; Testicular Neoplasms; Treatment Outcome; Urologic Neoplasms; Vinblastine	2005
What news in urological cancer. La Tunisie medicale, 2005, Volume: 83 Suppl 12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoplasm Staging; Palliative Care; Patient Selection; Survival Rate; Taxoids; Treatment Outcome; Urologic Neoplasms; Vinblastine	2005
[Recent progress in the treatment for urothelial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bridged-Ring Compounds; Cisplatin; Deoxycytidine; Doxorubicin; Endoscopy, Gastrointestinal; Evidence-Based Medicine; Gemcitabine; Humans; Laparoscopy; Laser Therapy; Methotrexate; Neoadjuvant Therapy; Taxoids; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2006
[Gemcitabine and pemetrexed in genito-urinary tumors treatment]. Bulletin du cancer, 2007, Volume: 94 Spec No Actualites Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Gemcitabine; Glutamates; Guanine; Humans; Kidney Neoplasms; Methotrexate; Pemetrexed; Urologic Neoplasms; Vinblastine	2007
Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Clinical Trials, Phase II as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Urologic Neoplasms	2000
[Gemcitabine and urothelial tumours]. Anti-cancer drugs, 2000, Volume: 11 Suppl 1 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Urologic Neoplasms	2000
Second-line treatment of advanced transitional cell carcinoma of the urothelial tract. Current opinion in urology, 2001, Volume: 11, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Survival Analysis; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium; Vinblastine	2001

Trials

55 trial(s) available for gemcitabine and Cancer of the Urinary Tract

Article	Year
Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma. Anticancer research, 2020, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Urologic Neoplasms	2020
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. The New England journal of medicine, 2020, 09-24, Volume: 383, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Maintenance Chemotherapy; Male; Middle Aged; Progression-Free Survival; Survival Analysis; Urologic Neoplasms; Urothelium	2020
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 08-01, Volume: 39, Issue:22 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Male; Neovascularization, Pathologic; Survival Analysis; Urinary Bladder Neoplasms; Urologic Neoplasms	2021
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Oct-01, Volume: 28, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Chaperones; Oligonucleotides, Antisense; Urologic Neoplasms	2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. European urology, 2018, Volume: 73, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA Damage; DNA Mutational Analysis; Female; Gemcitabine; Humans; Ipilimumab; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2018
Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Platinum Compounds; Progression-Free Survival; Response Evaluation Criteria in Solid Tumors; Urologic Neoplasms	2018
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Sorafenib; Survival Analysis; Urologic Neoplasms	2018
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma. Urologic oncology, 2014, Volume: 32, Issue:1 Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Prognosis; Treatment Outcome; Urologic Neoplasms; Urothelium	2014
Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma. International journal of clinical oncology, 2014, Volume: 19, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neutropenia; Taxoids; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms; Urothelium; Young Adult	2014
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05). BJU international, 2014, Volume: 113, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Male; Niacinamide; Phenylurea Compounds; Prospective Studies; Sorafenib; Treatment Outcome; Urologic Neoplasms	2014
Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma. Investigational new drugs, 2014, Volume: 32, Issue:1 Topics: Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Demography; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis; Treatment Outcome; Urologic Neoplasms; Urothelium	2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European urology, 2015, Volume: 67, Issue:4 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Indoles; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome; Urologic Neoplasms	2015
Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy. PloS one, 2015, Volume: 10, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA-Binding Proteins; Endonucleases; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Predictive Value of Tests; Ribonucleoside Diphosphate Reductase; Survival Rate; Tumor Suppressor Proteins; Urologic Neoplasms	2015
Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study. Urology, 2016, Volume: 89 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Deoxycytidine; Doxorubicin; Drug Therapy, Combination; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Kidney; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Urologic Neoplasms	2016
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gefitinib; Gemcitabine; Humans; Male; Middle Aged; Quinazolines; Urologic Neoplasms	2009
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine	2009
The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen. International journal of clinical oncology, 2011, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Failure; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine	2011
Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma. International journal of clinical oncology, 2011, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Taxoids; Urologic Neoplasms; Vinblastine	2011
Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99). European urology, 2011, Volume: 60, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Decision Support Techniques; Deoxycytidine; Female; Gemcitabine; Germany; Hemoglobins; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Patient Selection; Regression Analysis; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine	2011
Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Paclitaxel; Survival Analysis; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2011
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Investigational new drugs, 2012, Volume: 30, Issue:5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemistry, Pharmaceutical; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Micelles; Middle Aged; Organoplatinum Compounds; Paclitaxel; Polyethylene Glycols; Polymers; Prognosis; Urologic Neoplasms	2012
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jan-10, Volume: 30, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Contraindications; Deoxycytidine; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Quality of Life; Surveys and Questionnaires; Survival Rate; Urologic Neoplasms; Vinblastine	2012
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Apr-01, Volume: 30, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Hemorrhage; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Analysis; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms; Urothelium	2012
Intermittent chemotherapy is a treatment choice for advanced urothelial cancer. Oncology, 2012, Volume: 83, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Paclitaxel; Prospective Studies; Quality of Life; Serum Albumin; Survival Rate; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium	2012
Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma. Clinical genitourinary cancer, 2013, Volume: 11, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Deoxycytidine; Dose Fractionation, Radiation; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urologic Neoplasms; Urothelium	2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Constipation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Treatment Outcome; Urologic Neoplasms; Urothelium	2013
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. Cancer, 2002, Aug-15, Volume: 95, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium	2002
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2). American journal of clinical oncology, 2002, Volume: 25, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Paclitaxel; Urologic Neoplasms	2002
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy. Cancer, 2003, May-01, Volume: 97, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Quality of Life; Survival Rate; Urologic Neoplasms	2003
Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group. Cancer, 2003, Jun-01, Volume: 97, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Taxoids; Urologic Neoplasms; Urothelium	2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]. Der Urologe. Ausg. A, 2003, Volume: 42, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Prospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine	2003
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. Cancer, 2004, Jan-01, Volume: 100, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neutropenia; Paclitaxel; Urologic Neoplasms	2004
A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer. The Canadian journal of urology, 2004, Volume: 11, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Outpatients; Treatment Outcome; Urologic Neoplasms	2004
Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study. British journal of cancer, 2005, Feb-28, Volume: 92, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Taxoids; Treatment Outcome; Urologic Neoplasms; Urothelium	2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Alkyl and Aryl Transferases; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Disease Progression; Farnesyltranstransferase; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Piperidines; Pyridines; Salvage Therapy; Survival Analysis; Urologic Neoplasms	2005
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Deoxycytidine; Female; Gemcitabine; Heart Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2005
Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. Japanese journal of clinical oncology, 2006, Volume: 36, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Urologic Neoplasms; Urothelium	2006
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Gemcitabine; Humans; Infusions, Intravenous; Organoplatinum Compounds; Oxaliplatin; Pain; Pain Measurement; Placebos; Treatment Outcome; Urologic Neoplasms	2006
Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma. Cancer, 2006, Jun-01, Volume: 106, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Survival Rate; Urologic Neoplasms	2006
Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:11 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Greece; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Patient Compliance; Taxoids; Treatment Outcome; Urologic Neoplasms	2006
Efficacy and safety of gemcitabine monotherapy in patients with transitional cell carcinoma after Cisplatin-containing therapy: a Japanese experience. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urologic Neoplasms; Urothelium	2007
Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study. Anti-cancer drugs, 2007, Volume: 18, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Taxoids; Treatment Outcome; Urologic Neoplasms; Urothelium	2007
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102. BJU international, 2008, Volume: 101, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gefitinib; Gemcitabine; Humans; Male; Middle Aged; Quinazolines; Treatment Outcome; Urologic Neoplasms; Urothelium	2008
Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Paclitaxel; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2007
Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy. Clinical genitourinary cancer, 2008, Volume: 6, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Prospective Studies; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome; Urologic Neoplasms	2008
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:12 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms	1997
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:8 Topics: Adult; Aged; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Hematologic Diseases; Humans; Influenza, Human; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Urologic Neoplasms	1998
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase II clinical trial. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Survival Analysis; Urologic Neoplasms	1999
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4 Topics: Aged; Agranulocytosis; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Nausea; Paclitaxel; Remission Induction; Urologic Neoplasms; Vomiting	2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2000
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trial. The Journal of urology, 2000, Volume: 164, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Neoplasm Staging; Urologic Neoplasms	2000
Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Methotrexate; Paclitaxel; Treatment Outcome; Urologic Neoplasms; Vinblastine	2000
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose Fractionation, Radiation; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Survival Analysis; Urologic Neoplasms	2000
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematuria; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pain; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Urination Disorders; Urologic Neoplasms	2001
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Salvage Therapy; Treatment Outcome; Urologic Neoplasms	2002

Other Studies

61 other study(ies) available for gemcitabine and Cancer of the Urinary Tract

Article	Year
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma. BJU international, 2023, Volume: 131, Issue:4 Topics: Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Methotrexate; Platinum; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2023
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy. European urology oncology, 2019, Volume: 2, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Computer Simulation; Cost-Benefit Analysis; Deoxycytidine; Drug Costs; Gemcitabine; Humans; Models, Economic; Progression-Free Survival; Quality-Adjusted Life Years; Sweden; Urologic Neoplasms	2019
Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin. International journal of clinical oncology, 2020, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Sarcopenia; Thrombocytopenia; Tomography, X-Ray Computed; Urologic Neoplasms	2020
Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2019, Oct-01, Volume: 20, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Muscle, Skeletal; Prognosis; Retrospective Studies; Sarcopenia; Survival Rate; Urologic Neoplasms	2019
Is it time to redefine cisplatin ineligibility in metastatic urothelial cancer? European journal of cancer (Oxford, England : 1990), 2020, Volume: 127 Topics: Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Urologic Neoplasms; Vinblastine	2020
Efficacy of a Newly Modified Short Hydration Method for Gemcitabine and Cisplatin Combination Chemotherapy in Patients with Urothelial Carcinoma. Oncology, 2020, Volume: 98, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Creatinine; Deoxycytidine; Female; Fluid Therapy; Gemcitabine; Humans; Hyponatremia; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sodium; Urinary Bladder Neoplasms; Urologic Neoplasms	2020
Risk Associated with Severe Hematological Toxicity in Patients with Urothelial Cancer Receiving Combination Chemotherapy of Gemcitabine and Cisplatin. Chemotherapy, 2020, Volume: 65, Issue:1-2 Topics: Aged; Antineoplastic Agents; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia; Urologic Neoplasms	2020
Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC. Journal of cancer research and clinical oncology, 2021, Volume: 147, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2021
Evaluation of renal function using cystatin C-based estimated glomerular filtration rate in patients with urothelial carcinoma treated with gemcitabine and cisplatin chemotherapy. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cystatin C; Deoxycytidine; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Urologic Neoplasms	2021
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma. Anticancer research, 2017, Volume: 37, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Survival Rate; Urologic Neoplasms	2017
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy. International journal of clinical oncology, 2018, Volume: 23, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Muscle, Skeletal; Prognosis; Retrospective Studies; Sarcopenia; Tomography, X-Ray Computed; Urologic Neoplasms	2018
The Combination of Gemcitabine, Cisplatin, and Paclitaxel as Salvage Chemotherapy for Advanced Urothelial Carcinoma. Acta medica Okayama, 2018, Volume: 72, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Salvage Therapy; Treatment Outcome; Urologic Neoplasms	2018
Factors that Predict Neutropenia in Korean Patients with Advanced Urothelial Cancer after Cisplatin- Based Systemic Chemotherapy. Urology journal, 2018, 07-10, Volume: 15, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Leukocyte Count; Methotrexate; Middle Aged; Neutropenia; Neutrophils; Republic of Korea; Risk Factors; Urologic Neoplasms; Vinblastine	2018
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma. International journal of clinical oncology, 2018, Volume: 23, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Urologic Neoplasms	2018
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma. Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Deoxycytidine; Doxorubicin; Drug Synergism; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; MAP Kinase Signaling System; Mice, Nude; Protein Kinase Inhibitors; Protein Kinases; RNA, Small Interfering; Urologic Neoplasms	2018
Chemotherapy regimen is associated with venous thromboembolism risk in patients with urothelial tract cancer. BJU international, 2019, Volume: 124, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Retrospective Studies; SEER Program; United States; Urologic Neoplasms; Venous Thromboembolism; Vinblastine	2019
Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy. The Annals of pharmacotherapy, 2019, Volume: 53, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Urologic Neoplasms; Urothelium	2019
Treatment of Metastatic Urothelial Cancer in 2018. JAMA oncology, 2019, Jun-01, Volume: 5, Issue:6 Topics: Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Carboplatin; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Immunotherapy; Programmed Cell Death 1 Receptor; Taxoids; Urologic Neoplasms; Urothelium	2019
Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study. International journal of surgery (London, England), 2019, Volume: 66 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Urologic Neoplasms	2019
Second-line systemic therapies for metastatic urothelial carcinoma: a population-based cohort analysis. Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome; Urologic Neoplasms; Urothelium	2019
[Gemcitabine and cisplatin (GC) or gemcitabine and carboplatin (GCarbo) in patients with metastatic urothelial cancer]. Hinyokika kiyo. Acta urologica Japonica, 2013, Volume: 59, Issue:1 Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Neoplasm Metastasis; Treatment Outcome; Urologic Neoplasms	2013
Low-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:11 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Urologic Neoplasms	2014
Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Prognosis; Salvage Therapy; Survival Analysis; Treatment Failure; Treatment Outcome; Urologic Neoplasms	2015
The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Slovakia; Survival Analysis; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2014
[Neoadjuvant chemotherapy for urothelial tumors]. La Revue du praticien, 2014, Volume: 64, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoadjuvant Therapy; Preoperative Care; Treatment Outcome; Urologic Neoplasms; Vinblastine	2014
Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer. International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium	2015
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes. Urologic oncology, 2015, Volume: 33, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Cisplatin; Cohort Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Survival Rate; Urologic Neoplasms	2015
Gemcitabine plus nedaplatin as salvage therapy is a favorable option for patients with progressive metastatic urothelial carcinoma after two lines of chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Salvage Therapy; Survival Rate; Urologic Neoplasms	2015
[Side effect and supportive care to combination of gemcitabine and cisplatin chemotherapy for the advanced urothelial cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73 Suppl 2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Urologic Neoplasms	2015
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urologic Neoplasms	2015
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Creatinine; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome; Urologic Neoplasms	2015
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients. International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting	2015
The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy. Urologic oncology, 2015, Volume: 33, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine	2015
[EFFICACY OF NEOADJUVANT GEMCITABINE AND CISPLATIN IN THE MANAGEMENT OF MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2015, Volume: 106, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Muscle, Skeletal; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder; Urologic Neoplasms	2015
Fatal acute cardiac vasculopathy during cisplatin-gemcitabine-bevacizumab (CGB) chemotherapy for advanced urothelial carcinoma. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:2 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma; Cisplatin; Deoxycytidine; Gemcitabine; Heart Diseases; Humans; Male; Urologic Neoplasms; Urothelium	2016
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP). BMC cancer, 2015, Oct-27, Volume: 15 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Platinum; Predictive Value of Tests; Treatment Failure; Urologic Neoplasms; Urothelium; Vinblastine	2015
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer, 2016, Mar-01, Volume: 122, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Transitional Cell; Case-Control Studies; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Incidence; Kidney Neoplasms; Kidney Pelvis; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Stroke; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Venous Thromboembolism	2016
Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine	2016
A Case of Gemcitabine and Cisplatin Chemotherapy in a Patient With Metastatic Urothelial Carcinoma Receiving Hemodialysis. Clinical genitourinary cancer, 2016, Volume: 14, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Male; Renal Dialysis; Urologic Neoplasms	2016
[Comparison of the Four-Week and Three-Week Regimens of GC Therapy for Urothelial Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urologic Neoplasms; Urothelium	2016
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study). International journal of clinical oncology, 2016, Volume: 21, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Drug Monitoring; Female; Gemcitabine; Humans; Japan; Kidney Function Tests; Male; Medication Therapy Management; Methotrexate; Retrospective Studies; Survival Rate; Urologic Neoplasms; Urothelium; Vinblastine	2016
The safety and effect of chemotherapy with short hydration for urothelial cancer on patients' quality of life. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Cisplatin; Creatinine; Deoxycytidine; Drug Therapy, Combination; Female; Fluid Therapy; Gemcitabine; Glomerular Filtration Rate; Humans; Kidney; Linear Models; Male; Middle Aged; Quality of Life; Treatment Outcome; Urologic Neoplasms	2016
[Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials]. Bulletin du cancer, 2016, Volume: 103, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carboplatin; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Programmed Cell Death 1 Receptor; Urologic Neoplasms; Vinblastine	2016
ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance. Cancer science, 2017, Volume: 108, Issue:2 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Body Weight; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Gemcitabine; Gene Fusion; Humans; Molecular Targeted Therapy; Point Mutation; Pyrazoles; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 3; Transcription Factors; Urologic Neoplasms	2017
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma. International journal of clinical oncology, 2017, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Quality of Life; Urologic Neoplasms	2017
Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function. Toxicology and applied pharmacology, 2017, 02-01, Volume: 316 Topics: Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Cytotoxins; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Inflammation; Urologic Neoplasms; Urothelium	2017
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Constipation; Deoxycytidine; Diarrhea; Feeding and Eating Disorders; Female; Gemcitabine; Humans; Male; Nausea; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Retrospective Studies; Treatment Outcome; Urologic Neoplasms	2017
[Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Gemcitabine; Hematologic Diseases; Humans; Methotrexate; Neoplasm Metastasis; Retrospective Studies; Taxoids; Urologic Neoplasms; Vinblastine	2008
Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. Urologia internationalis, 2010, Volume: 85, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms	2010
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium	2010
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium	2010
Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. Journal of ethnopharmacology, 2011, Sep-01, Volume: 137, Issue:1 Topics: 4-Butyrolactone; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cinnamomum; Cisplatin; Cytochromes c; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Gemcitabine; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Plant Preparations; Plant Stems; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Time Factors; Tumor Suppressor Protein p53; Urologic Neoplasms; Urothelium	2011
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:3 Topics: Aged; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Pain; Pain Measurement; Retrospective Studies; Salvage Therapy; Treatment Outcome; Urologic Neoplasms; Urothelium	2012
Combined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency. International journal of clinical oncology, 2013, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Male; Neoplasm Metastasis; Renal Insufficiency; Urologic Neoplasms; Urothelium	2013
[The effect of presurgical gemcitabine cisplatin chemotherapy for urothelial carcinoma]. Hinyokika kiyo. Acta urologica Japonica, 2012, Volume: 58, Issue:8 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urologic Neoplasms	2012
Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium. International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:7 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Urologic Neoplasms; Urothelium	2004
[Gemcitabine and cisplatin therapy in advanced or metastatic urothelial cancer: comparison of side effect with MVAC (methotrexate, vinblastine, doxorubicin, and cisplatin)]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2006, Volume: 97, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Quality of Life; Urologic Neoplasms; Vinblastine	2006
[Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy]. Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Urologic Neoplasms; Vinblastine	2006
Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience. International journal of clinical oncology, 2007, Volume: 12, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Female; Gemcitabine; Hospitals, University; Humans; Japan; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Urologic Neoplasms	2007
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology, 2007, Volume: 73, Issue:5-6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Patient Selection; Quality of Life; Survival Analysis; Treatment Outcome; Urologic Neoplasms	2007
Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Treatment Outcome; Urologic Neoplasms; Urothelium	2001